glp-1 stroke risk may have potential to improve poststroke outcomes, prognosis GLP-1 receptor agonists in stroke

2025 Apr;24(4):e70163

In a 40-week double blinded, placebo-controlled study, weekly injections of Tirzepatide (15mg) in Type 2 Diabetes Mellitus (T2DM) patients was capable of reducing body weight by an average of 10.1%, over placebo at 40 weeks

Hepatol Int (2022) 16:13907

Similar content being viewed by others Introduction The anorexigenic gut hormone peptide YY (PYY) and the incretin glucagon-like peptide 1 (GLP-1) acutely suppress appetite following their co-release from enteroendocrine L cells

Similarly, GSH was able to reduce cisplatin-induced nephrotoxicity in rats as reflected by decreased levels of MDA and increased levels of GSH 61

If youve struggled with weight loss in the past or found that traditional methods havent worked for you, GLP-1 medications could be the solution youve been looking for